HBI Deals+Insights / Business Models and Strategy
We talk to the CEO of AWAK, a Singaporean medtech group that has developed a portable peritoneal dialysis device, which just raised $40m to accelerate its development and commercialisation in the US and internationally. What does it say about investor appetite for dialysis, considering the slow Diaverum sale process?